FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.

Li X, Su M, Luo J, Han D, Qing L, Zhang D, Liu S, Liu J, Fu G

DOI: 10.1016/j.urolonc.2026.07.027
Published: 2026 Sep 5
Container: Urologic oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2026.07.027,
  title = {FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.},
  author = {Li X and Su M and Luo J and Han D and Qing L and Zhang D and Liu S and Liu J and Fu G},
  year = {2026},
  journal = {Urologic oncology},
  doi = {10.1016/j.urolonc.2026.07.027},
  url = {https://doi.org/10.1016/j.urolonc.2026.07.027}
}

RIS

TY  - JOUR
TI  - FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.
AU  - Li X
AU  - Su M
AU  - Luo J
AU  - Han D
AU  - Qing L
AU  - Zhang D
AU  - Liu S
AU  - Liu J
AU  - Fu G
PY  - 2026
JO  - Urologic oncology
DO  - 10.1016/j.urolonc.2026.07.027
UR  - https://doi.org/10.1016/j.urolonc.2026.07.027
ER  -

APA

X, L., M, S., J, L., D, H., L, Q., D, Z., S, L., J, L., & G, F. (2026). FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.07.027

Source records

pubmed · retrieved 2026-09-26T11:11:23.524Z